TABLE 1.
Receptor Status | Age (year) | Maximum Diameter | Minimum Diameter | ADC Value of RS‐EPI (×10−3 cm2) | ADC Value of SS‐EPI (×10−3 cm2) | Normalized ADC Value of RS‐EPI | Normalized ADC Value of SS‐EPI |
---|---|---|---|---|---|---|---|
ER | |||||||
Negative (n = 56) | 51.59 ± 9.07 | 4.01 ± 1.67 | 2.58 ± 1.12 | 0.84 ± 0.12 | 0.80 ± 0.10 | 0.46 ± 0.11 | 0.52 ± 0.13 |
Positive (n = 95) | 50.01 ± 11.62 | 3.30 ± 1.69 | 2.02 ± 0.92 | 0.83 ± 0.11 | 0.78 ± 0.10 | 0.48 ± 0.11 | 0.53 ± 0.12 |
P value | 0.385 | 0.002 | <0.001 | 0.510 | 0.480 | 0.543 | 0.282 |
PR | |||||||
Negative (n = 92) | 52.33 ± 10.31 | 3.86 ± 1.86 | 2.46 ± 1.10 | 0.82 ± 0.11 | 0.78 ± 0.11 | 0.46 ± 0.11 | 0.51 ± 0.13 |
Positive (n = 59) | 47.90 ± 10.93 | 3.10 ± 1.35 | 1.85 ± 0.80 | 0.85 ± 0.11 | 0.80 ± 0.10 | 0.50 ± 0.11 | 0.56 ± 0.11 |
P‐value | 0.013 | 0.006 | <0.001 | 0.192 | 0.480 | 0.020 | 0.002 |
HER‐2 | |||||||
Negative (n = 100) | 51.00 ± 11.25 | 3.43 ± 1.68 | 2.20 ± 1.08 | 0.81 ± 0.11 | 0.78 ± 0.11 | 0.46 ± 0.11 | 0.52 ± 0.12 |
Positive (n = 51) | 49.90 ± 9.75 | 3.82 ± 1.76 | 2.27 ± 0.93 | 0.87 ± 0.10 | 0.80 ± 0.10 | 0.51 ± 0.11 | 0.55 ± 0.13 |
P value | 0.572 | 0.204 | 0.365 | 0.001 | 0.199 | 0.010 | 0.173 |
Ki‐67 | |||||||
<20% (n = 36) | 51.44 ± 10.63 | 3.18 ± 1.22 | 1.80 ± 0.60 | 0.84 ± 0.11 | 0.80 ± 0.11 | 0.50 ± 0.10 | 0.55 ± 0.12 |
≥20% (n = 115) | 50.33 ± 10.81 | 3.68 ± 1.83 | 2.36 ± 1.10 | 0.83 ± 0.12 | 0.79 ± 0.10 | 0.46 ± 0.11 | 0.52 ± 0.12 |
P value | 0.589 | 0.210 | 0.003 | 0.398 | 0.551 | 0.029 | 0.154 |
Bold values indicate statistically significant in P values.
ER = estrogen receptor; PR = progesterone receptor; HER‐2 = human epidermal growth factor receptor‐2; ADC = apparent diffusion coefficient.